Design of the PROUD study: PCR faeces testing in outpatients with diarrhoea

Alwin Schierenberg1, Martine D Nipshagen2, Berna D L Broekhuizen3

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, P.O. Box 85500, 3584 CG, Utrecht, The Netherlands. a.schierenberg@umcutrecht.nl.

BMC Infectious Diseases
|February 3, 2016
PubMed
Abstract

Insights

The PROUD study evaluated polymerase chain reaction (PCR) for infectious intestinal disease (IID) diagnostics in primary care. It assessed PCR

Area of Science:

  • Clinical diagnostics
  • Infectious diseases
  • Public health microbiology

Background:

  • Infectious intestinal disease (IID) is a significant cause of morbidity and general practitioner (GP) visits in developed nations.
  • Polymerase chain reaction (PCR) offers improved sensitivity and speed for enteropathogen detection compared to traditional methods.
  • The cost-effectiveness and real-world impact of introducing PCR in primary care for IID remain unquantified.

Purpose of the Study:

  • To determine the health effects and cost-effectiveness of implementing PCR diagnostics for IID in primary care.
  • To estimate the current occurrence of major enteropathogens in primary care patients presenting with IID.
  • To provide updated prevalence data for enteropathogens using sensitive PCR techniques.

Main Methods:

  • A before-and-after cohort study design was employed, comparing conventional testing (2010-2011) with PCR testing (2013-2014).
  • Data on patient characteristics, healthcare utilization, and disease outcomes were collected from electronic records.
  • Routine faecal samples from 2014 were screened using PCR to determine enteropathogen prevalence.

Main Results:

  • The study quantifies the costs and health effects associated with the introduction of PCR techniques.
  • It provides updated and sensitive estimates of enteropathogen occurrence in primary care settings.
  • Comparison between conventional and PCR periods will elucidate the impact of diagnostic shifts.

Conclusions:

  • The PROUD study provides crucial data on the value of PCR diagnostics in primary care for IID.
  • Findings will inform healthcare policy regarding the adoption of advanced diagnostic technologies.
  • Updated enteropathogen prevalence data will aid in understanding the epidemiology of IID.